Drug Patent Expirations in April 2014

Drug Patent Expirations for April 2014

TradenameApplicantGeneric NamePatent NumberPatent Expiration
MAXALT-MLTMerckrizatriptan benzoate5,457,895*PEDApr 1, 2014
FROVAEndo Pharmsfrovatriptan succinate5,616,603Apr 1, 2014
ABELCETSigma Tauamphotericin b5,616,334Apr 1, 2014
BROVANASunovionarformoterol tartrate6,589,508Apr 3, 2014
INCRELEXIpsen Incmecasermin recombinant6,207,640Apr 7, 2014
VIRACEPTAgouronnelfinavir mesylate5,952,343*PEDApr 7, 2014
NIZORAL A-DMcneil Consketoconazole5,456,851Apr 7, 2014
VIRACEPTAgouronnelfinavir mesylate5,484,926*PEDApr 7, 2014
VIRACEPTAgouronnelfinavir mesylate6,162,812*PEDApr 7, 2014
INVEGA SUSTENNAJanssen Pharmspaliperidone palmitate5,254,556*PEDApr 15, 2014
ATELVIAWarner Chilcott Llcrisedronate sodium5,622,721Apr 21, 2014
ALREXBausch And Lombloteprednol etabonate5,540,930*PEDApr 25, 2014
LOTEMAXBausch And Lombloteprednol etabonate5,540,930*PEDApr 25, 2014
ZYLETBausch And Lombloteprednol etabonate; tobramycin5,540,930*PEDApr 25, 2014
ALREXBausch And Lombloteprednol etabonate5,747,061*PEDApr 25, 2014
LOTEMAXBausch And Lombloteprednol etabonate5,747,061*PEDApr 25, 2014
ZYLETBausch And Lombloteprednol etabonate; tobramycin5,747,061*PEDApr 25, 2014
ABREVAGlaxosmithklinedocosanol4,874,794Apr 28, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog